Patents by Inventor Benjamin R. McDonald

Benjamin R. McDonald has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBSTITUTED CHROMANES, ANALOGS THEREOF, AND METHODS OF USE AND SYNTHESIS
    Publication number: 20230339879
    Abstract: Disclosed are chromane compounds, analogs thereof, and methods of their synthesis and use. The compounds may be synthesized by methods involving reductive annulations of arylidene malonates with unsaturated electrophiles using photoredox/Lewis acid cooperative catalysis. The compounds may be formulated in a pharmaceutical composition for treating one of the aforementioned diseases or disorders.
    Type: Application
    Filed: March 21, 2023
    Publication date: October 26, 2023
    Inventors: Karl A. Scheidt, Rick C. Betori, Benjamin R. McDonald
  • Substituted chromanes, analogs thereof, and methods of use and synthesis
    Patent number: 11639340
    Abstract: Disclosed are chromane compounds, analogs thereof, and methods of their synthesis and use. The compounds may be synthesized by methods involving reductive annulations of arylidene malonates with unsaturated electrophiles using photoredox/Lewis acid cooperative catalysis. The compounds may be formulated in a pharmaceutical composition for treating one of the aforementioned diseases or disorders.
    Type: Grant
    Filed: July 8, 2020
    Date of Patent: May 2, 2023
    Assignee: NORTHWESTERN UNIVERSITY
    Inventors: Karl A. Scheidt, Rick C. Betori, Benjamin R. McDonald
  • SUBSTITUTED CHROMANES, ANALOGS THEREOF, AND METHODS OF USE AND SYNTHESIS
    Publication number: 20210009547
    Abstract: Disclosed are chromane compounds, analogs thereof, and methods of their synthesis and use. The compounds may be synthesized by methods involving reductive annulations of arylidene malonates with unsaturated electrophiles using photoredox/Lewis acid cooperative catalysis. The compounds may be formulated in a pharmaceutical composition for treating one of the aforementioned diseases or disorders.
    Type: Application
    Filed: July 8, 2020
    Publication date: January 14, 2021
    Applicant: NORTHWESTERN UNIVERSITY
    Inventors: Karl A. Scheidt, Rick C. Betori, Benjamin R. McDonald